Chemical Structure For Lansoprazole (3e029e9f 0db0 41b7 8552 4728da9bad78 01)
Lansoprazole
Product Images NDC 54868-6205
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 54868-6205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (3e029e9f 0db0 41b7 8552 4728da9bad78 02)
This is a graph showing the mean severity of daytime heartburn over a period of days from the start of treatment. There are three treatment groups: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The severity of heartburn is measured on the Y-axis and the number of days from the start of treatment is on the X-axis.*
Figure 2 (3e029e9f 0db0 41b7 8552 4728da9bad78 03)
This is a chart showing the mean severity of night heartburn for patients taking a placebo, e-lansoprazole 15 mg QD, and 4-lansoprazole 30 mg QD over 60 days from the start of treatment.*
Lansoprazole Delayed-release Orally Disintegrating Tablets 30 mg (6205)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
